Benzonatate - Drug Monograph

Comprehensive information about Benzonatate including mechanism, indications, dosing, and safety information.

Introduction

Benzonatate is a non-narcotic antitussive medication approved by the FDA in 1958. It is chemically related to local anesthetics such as tetracaine and is classified as a peripherally-acting cough suppressant. Unlike centrally-acting opioid antitussives, benzonatate works through local anesthetic effects on the respiratory tract.

Mechanism of Action

Benzonatate exerts its antitussive effect through anesthesia of the stretch receptors located in the respiratory passages, lungs, and pleura. By numbing these receptors, it reduces the cough reflex at its peripheral source. The drug may also have a central effect on the cough center in the medulla, though this is considered secondary to its peripheral action.

Indications

Benzonatate is indicated for the symptomatic relief of cough. It is particularly useful for:

  • Acute cough associated with respiratory tract infections
  • Chronic cough in various respiratory conditions
  • Post-operative cough

Dosage and Administration

Adults and children over 10 years: 100 mg three times daily as needed, up to 600 mg daily Administration: Swallow capsules whole; do not crush, chew, or dissolve in mouth Special populations:
  • Renal impairment: Use with caution; no specific dosage adjustment recommendations
  • Hepatic impairment: Use with caution; limited data available
  • Elderly: Consider starting at lower end of dosing range
  • Pediatrics: Safety and effectiveness under age 10 not established

Pharmacokinetics

Absorption: Rapidly absorbed from GI tract Distribution: Distributed throughout the body Metabolism: Hydrolyzed by esterases to metabolites including para-aminobenzoic acid (PABA) Elimination: Primarily renal excretion; half-life unknown Onset of action: 15-20 minutes Duration of effect: 3-8 hours

Contraindications

  • Hypersensitivity to benzonatate or related compounds
  • History of allergic reactions to PABA or procaine
  • Children under 10 years of age

Warnings and Precautions

Black Box Warning: Risk of severe hypersensitivity reactions including bronchospasm, laryngospasm, and cardiovascular collapse, particularly if capsules are chewed or dissolved in mouth Other precautions:
  • CNS effects: May cause sedation; caution when operating machinery
  • Psychiatric effects: Rare reports of confusion and visual hallucinations
  • Pregnancy: Category C - use only if potential benefit justifies potential risk
  • Lactation: Not recommended; excreted in breast milk

Drug Interactions

  • CNS depressants: Additive sedation with alcohol, benzodiazepines, opioids
  • Local anesthetics: Potential for additive effects
  • Cholinesterase inhibitors: Theoretical interaction due to ester hydrolysis

Adverse Effects

Common (≥1%):
  • Sedation
  • Dizziness
  • Headache
  • Constipation
  • Nausea
  • Nasal congestion
Serious (<1%):
  • Hypersensitivity reactions
  • Bronchospasm
  • Laryngospasm
  • Cardiovascular collapse
  • CNS depression
  • Visual hallucinations

Monitoring Parameters

  • Cough frequency and severity
  • Respiratory status
  • CNS effects (sedation, dizziness)
  • Signs of hypersensitivity reactions
  • Overall therapeutic response

Patient Education

  • Swallow capsules whole; do not chew or break
  • Report any signs of allergic reaction immediately (rash, difficulty breathing, swelling)
  • Avoid alcohol and other CNS depressants during therapy
  • Be cautious when driving or operating machinery
  • Store at room temperature away from children (risk of accidental ingestion)
  • Do not exceed recommended dosage
  • Contact healthcare provider if cough persists beyond 7 days or is accompanied by fever, rash, or persistent headache

References

1. FDA Prescribing Information: Tessalon (benzonatate) capsules 2. American College of Chest Physicians Cough Guidelines (2018) 3. Lexicomp Drug Information: Benzonatate 4. Micromedex Solutions: Benzonatate monograph 5. Clinical Pharmacology [database online]: Benzonatate 6. Chest Journal: "Diagnosis and Management of Cough Executive Summary" (2006) 7. Drug Facts and Comparisons (2023 edition)

Note: This monograph provides general information for healthcare professionals. Always consult current prescribing information and clinical guidelines for specific patient care decisions.

Medical Disclaimer

The information provided in this article is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

The content on MedQuizzify is designed to support, not replace, the relationship that exists between a patient and their healthcare provider. If you have a medical emergency, please call your doctor or emergency services immediately.

How to Cite This Article

admin. Benzonatate - Drug Monograph. MedQuizzify [Internet]. 2025 Sep 07 [cited 2025 Sep 07]. Available from: http://medquizzify.pharmacologymentor.com/blog/drug-monograph-benzonatate

Enjoyed this post?

Subscribe to our newsletter and get more educational insights, quiz tips, and learning strategies delivered weekly to your inbox.